---
pmcid: PMC8506703
image_filename: atm-09-18-1441-f5.jpg
figure_link: /pmc/articles/PMC8506703/figure/f5/
number: Figure 5
figure_title: ''
caption: 'CALD1 promoted the expression of PD-L1 via the JAK/STAT signaling pathway.
  (A) GSEA results of CALD1 in TCGA database. (B) WB analysis after IFN-Î³ treatment.
  (C-D) Cell viability assay measured using the CCK-8. (E) Cell cycle analysis was
  measured by flow cytometry for four groups. (F,G) Cell apoptosis was measured by
  flow cytometry for four groups. (H,I) PD-L1 surface-antigen detection using flow
  cytometry. (J) WB analysis after ruxolitinib treatment. * vs. Vector, P<0.05; **
  vs. Vector, P<0.01; *** vs. Vector, P<0.001; #vs. CALD1 OE, P<0.05; ##vs. CALD1
  OE, P<0.01; ###vs. CALD1 OE, P<0.001. GSEA, gene set enrichment analysis; TCGA,
  The Cancer Genome Atlas; CCK-8, Cell Counting Kit-8; WB, western blot; OE, overexpression.'
article_title: CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT
  signaling pathway.
citation: Cheng Li, et al. Ann Transl Med. 2021 Sep;9(18):1441.

doi: 10.21037/atm-21-4192
journal_title: Annals of Translational Medicine
journal_nlm_ta: Ann Transl Med
publisher_name: AME Publishing Company

keywords:
- CALD1
- PD-L1
- bladder cancer (BC)
- JAK/STAT signaling pathway
- weighed gene co-expression network analysis (WGCNA)

---
